Latest Period
n/a
Security Snapshot
Yarrow Bioscience, Inc. - Common Stock, par value $0.0001 per share (YARW) Institutional Ownership
CUSIP: 92941V407
13F Institutional Holders and Ownership History
Institutions Reporting
Shares (Excl. Options)
Price
$32.99
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- YARW on Nasdaq
- Shares outstanding
- 670,455
- SEC-reported price per share
- $32.99
Key facts
- YARW - Yarrow Bioscience, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 92941V407.
- Latest finished 13F holder period is not available.
- 9 significant owners is listed from Schedule 13D/13G reporting.
Change
- Quarterly ownership records are not available yet for this CUSIP.
- This page updates as SEC-backed holdings history becomes available.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
92941V407
Latest holder period
n/a
13F holders
13D/G owners
9
CIK / CUSIP context first
YARW full holder history
VYNE Therapeutics Inc. SEC filings
VYNE Therapeutics Inc. company facts
VYNE Therapeutics Inc. insider transactions
Broader feeds
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
9
Security
YARW
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Logos Global Management LP | 11% | +8% | 286,308 | +3.5% | Logos Global Management LP | 31 Jul 2026 | ||
| venBio Global Strategic Fund V, L.P. | 10% | 279,340 | venBio Global Strategic Fund V, L.P. | 27 Jul 2026 | ||||
| PERCEPTIVE ADVISORS LLC | 10% | 266,756 | Perceptive Advisors LLC | 27 Jul 2026 | ||||
| Janus Henderson Group Ltd. | 10% | 266,712 | JANUS HENDERSON GROUP Ltd. | 31 Jul 2026 | ||||
| RTW Fund Group GP, LLC | 10% | 266,307 | RTW Fund Group GP, LLC | 27 Jul 2026 | ||||
| ORBIMED ADVISORS LLC | 10% | 266,306 | ORBIMED ADVISORS LLC | 27 Jul 2026 | ||||
| AI Biotechnology LLC | 6% | 178,180 | AI Biotechnology LLC | 27 Jul 2026 | ||||
| Zhang Xiaofan | 0.6% | 162,452 | Zhang Xiaofan | 13 Aug 2026 | ||||
| ADAR1 Capital Management, LLC | 8.8% | 59,000 | ADAR1 Capital Management, LLC | 30 Jun 2026 |